Tomer Cohen filed an Initial Statement of Beneficial Ownership (Form 3) with the SEC on November 17, 2026, disclosing his status as a newly appointed director of Oscar Health, Inc., with the event date recorded as November 13, 2026.

Key Highlights

  • New director: Tomer Cohen is identified as a director of Oscar Health, Inc., listed on NASDAQ:OSCR, according to the filing.
  • Event date: The date of the event requiring the statement is listed as November 13, 2026.
  • No securities held: The filing states, "No securities are beneficially owned," with both Table I and Table II containing no entries.
  • Individual filing: The form was filed by one reporting person and signed by Melissa Curtin as Attorney-in-Fact on November 17, 2026.
  • Power of Attorney: The filing references Exhibit 24, a Power of Attorney, as an explanation of responses.

Tomer Cohen Joins Oscar Health Board With No Initial Securities Position

According to the Form 3 filed with the SEC, Tomer Cohen, whose address is listed as 75 Varick Street, 5th Floor, New York, New York 10013, submitted an Initial Statement of Beneficial Ownership in connection with his role as a director of Oscar Health, Inc. The event triggering the filing is dated November 13, 2026, and the form was filed on November 17, 2026.

The filing discloses that Cohen holds no beneficial ownership of securities in Oscar Health at the time of filing. Both Table I, covering non-derivative securities, and Table II, covering derivative securities such as puts, calls, warrants, options, and convertible securities, are blank. The filing explicitly states: "No securities are beneficially owned."

The form was signed by Melissa Curtin as Attorney-in-Fact, with a Power of Attorney referenced as Exhibit 24. The filing was submitted as an individual filing by one reporting person, with Cohen identified solely as a director and no officer title or other relationship noted.

What Was Disclosed

Tomer Cohen filed a Form 3 as a new director of Oscar Health, Inc., reporting that he beneficially owns no securities of the company as of the event date of November 13, 2026.